Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Mohanty, Bibhu D; Looser, Patrick M; Gokanapudy, Lakshmi R; Handa, Rishi; Mohanty, Sudipta; Choi, Sharon S; Goldman, Martin E; Fuster, Valentin; Halperin, Jonathan L

Mohanty, Bibhu D; Looser, Patrick M; Gokanapudy, Lakshmi R; Handa, Rishi; Mohanty, Sudipta; Choi, Sharon S; Goldman, Martin E; Fuster, Valentin; Halperin, Jonathan L.

Afiliación

Mohanty BD; Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai Heart Hospital, New York, NY, USA.
Looser PM; Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA patrick.looser@mountsinai.org.
Gokanapudy LR; St George's University School of Medicine, Grenada, West Indies.
Handa R; Department of Medicine, Morristown Medical Center, Morristown, NJ, USA.
Mohanty S; University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Choi SS; Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA.
Goldman ME; Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai Heart Hospital, New York, NY, USA.
Fuster V; Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai Heart Hospital, New York, NY, USA.
Halperin JL; Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai Heart Hospital, New York, NY, USA.

Vasc Med ; 19(3): 190-204, 2014 Jun.

Article en En | MEDLINE | ID: mdl-24879715

Palabras clave

atrial fibrillation; oral anticoagulants; stroke prevention

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Vasc Med Asunto de la revista: ANGIOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Buscar en Google

Imprimir

XML

PubMed Links